PKG II effectively reversed EGF‐induced protein expression alterations in human gastric cancer cell lines

PKG II effectively reversed EGF‐induced protein expression alterations in human gastric cancer... Abbreviations2‐DEtwo‐dimensional electrophoresisCANacetonitrileCHAPS3‐[(3‐cholamidopropyl)‐dimethylammonio]‐1‐propanesulfonateDMEMDulbecco's Modified Eagle's MediaEGFepidermal growth factorEGFRepidermal growth factor receptorFUBP1far upstream element‐binding protein 1GCgastric cancerIEFisoelectric focusingIPGimmobilized pH gradientPKG IItype II cGMP‐dependent protein kinaseRTKsreceptor tyrosine kinasesIntroductionEpidermal growth factor receptor (EGFR) is a trans‐membrane glycoprotein which contains extracellular, trans‐membrane, and tyrosine kinase domains (Lemmon and Schlessinger, ). The over‐expression of EGF and EGFR shows correlation with metastasis, resistance to chemotherapy, and poor prognosis of numerous cancers (Tahara et al., ; Mitani et al., ; Yu et al., ). For example, many research data showed that EGF and EGFR were up‐regulated in gastric cancer (GC), and were involved in the invasion and metastasis of the tumor (Ito et al., ; Yasui et al., , ; Yoshida et al., ). After binding with natural ligands, such as EGF and TGF‐α, EGFRs undergo dimerization, auto‐phosphorylation and activation (Warren and Landgraf, ). The activated EGFR recruits adapter proteins, including GRB2, PLC and Cbl, to trigger downstream signaling (Ullrich and Schlessinger, ) and induce the changes of biological activities of the cells, such as proliferation, migration, and apoptosis (Citri and Yarden, ; Ferguson, ; Kim et al., ). Type II cGMP dependent protein kinase (PKG II) is a serine/threonine kinase and displays an important role in http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cell Biology International Wiley

PKG II effectively reversed EGF‐induced protein expression alterations in human gastric cancer cell lines

Loading next page...
 
/lp/wiley/pkg-ii-effectively-reversed-egf-induced-protein-expression-alterations-CvM6WTtk0U
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
© 2018 International Federation for Cell Biology
ISSN
1065-6995
eISSN
1095-8355
D.O.I.
10.1002/cbin.10912
Publisher site
See Article on Publisher Site

Abstract

Abbreviations2‐DEtwo‐dimensional electrophoresisCANacetonitrileCHAPS3‐[(3‐cholamidopropyl)‐dimethylammonio]‐1‐propanesulfonateDMEMDulbecco's Modified Eagle's MediaEGFepidermal growth factorEGFRepidermal growth factor receptorFUBP1far upstream element‐binding protein 1GCgastric cancerIEFisoelectric focusingIPGimmobilized pH gradientPKG IItype II cGMP‐dependent protein kinaseRTKsreceptor tyrosine kinasesIntroductionEpidermal growth factor receptor (EGFR) is a trans‐membrane glycoprotein which contains extracellular, trans‐membrane, and tyrosine kinase domains (Lemmon and Schlessinger, ). The over‐expression of EGF and EGFR shows correlation with metastasis, resistance to chemotherapy, and poor prognosis of numerous cancers (Tahara et al., ; Mitani et al., ; Yu et al., ). For example, many research data showed that EGF and EGFR were up‐regulated in gastric cancer (GC), and were involved in the invasion and metastasis of the tumor (Ito et al., ; Yasui et al., , ; Yoshida et al., ). After binding with natural ligands, such as EGF and TGF‐α, EGFRs undergo dimerization, auto‐phosphorylation and activation (Warren and Landgraf, ). The activated EGFR recruits adapter proteins, including GRB2, PLC and Cbl, to trigger downstream signaling (Ullrich and Schlessinger, ) and induce the changes of biological activities of the cells, such as proliferation, migration, and apoptosis (Citri and Yarden, ; Ferguson, ; Kim et al., ). Type II cGMP dependent protein kinase (PKG II) is a serine/threonine kinase and displays an important role in

Journal

Cell Biology InternationalWiley

Published: Jan 1, 2018

Keywords: ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial